JNJ

US government agencies file objection to J&J's $9B talc bankruptcy settlement
Fierce Pharma
Wed, 01/29/25 - 11:46 am
JNJ
bankruptcy
VA
HHS
J&J is all in on tau-targeted Alzheimer’s candidates. Will the approach lead to more effective treatments?
Pharma Voice
Fri, 01/24/25 - 11:32 am
JNJ
anti-tau
Alzheimer's disease
R&D
J&J joins Pfizer in detailing impact of Part D redesign
BioPharma Dive
Wed, 01/22/25 - 07:23 pm
JNJ
Pfizer
Medicare Part D
J&J oncology sales grow, but shares slide on outlook
BioPharma Dive
Wed, 01/22/25 - 12:01 pm
JNJ
earnings
oncology
Multiple Myeloma
JPM25 Recap: The Medtech Moments That Have the Industry Buzzing
Medical Devices and Diagnostics Industry
Tue, 01/21/25 - 07:10 pm
Medtech
JPMHC 2025
Illumina
PFA
JNJ
Medtronic
Boston Scientific
CGMs
Intuitive Surgical
robotic surgery
Embecta
renal denervation
FDA approves Johnson & Johnson’s nasal spray for depression as standalone treatment
CNBC
Tue, 01/21/25 - 11:34 am
JNJ
FDA
major depressive disorder
Spravato
ketamine
EU approves endometrial, lung cancer drugs from GSK and J&J
Pharmaphorum
Tue, 01/21/25 - 11:10 am
Eurioe
GSK
JNJ
endometrial cancer
lung cancer
Jemperli
Rybrevant
Lazcluze
By the numbers: J&J, GSK lead J.P. Morgan deal announcements in 2025, the largest turnout in years
Pharma Voice
Thu, 01/16/25 - 11:02 am
JPMHC 2025
M&A
JNJ
Intra-Cellular Therapeutics
GSK
IDRx
J&J to buy psychiatric drug developer Intra-Cellular for $14.6B
BioPharma Dive
Mon, 01/13/25 - 11:19 am
JNJ
Intra-Cellular Therapies
JPMHC 2025
M&A
psychiatric disease
Sanofi scores with its subcutaneous version of Sarclisa as it tries to play catch up with J&J's Darzalex
Fierce Pharma
Thu, 01/9/25 - 11:55 am
JNJ
Darzalex
Sanofi
Sarclisa
Multiple Myeloma
J&J Halts PFA Cases Amid Stroke Reports
Medical Devices and Diagnostics Industry
Wed, 01/8/25 - 11:18 pm
Medtech
JNJ
Varipulse
stroke
pulse field ablation
J&J says its lung cancer drug combination keeps people alive longer
CNBC
Tue, 01/7/25 - 11:13 am
JNJ
Rybrevant
Lazcluze
AstraZeneca
Tagrisso
clinical trials
lung cancer
Big Pharma layoff rounds jump 281% in '24, but overall industry rates similar to '23
Fierce Biotech
Mon, 01/6/25 - 10:58 am
layoffs
biotech
Pfizer
JNJ
Bristol Myers Squibb
Roivant
How pharma was instrumental in President Jimmy Carter’s global health efforts
Pharma Voice
Fri, 01/3/25 - 09:57 am
Jimmy Carter
Merck
GSK
JNJ
Amgen
6 Critical Developments That Could Define the Medical Device Industry in 2025
Medical Devices and Diagnostics Industry
Thu, 01/2/25 - 11:20 am
devices
Medtech
Europe
Medtronic
Abbott Labs
CGMs
JNJ
robotic surgery
Donald Trump
M&A
PFA to surpass radiofrequency ablation in 2025: Citi survey
Medtech Dive
Tue, 12/17/24 - 12:01 pm
Medtech
pulsed field ablation
radiofrequency ablation
Medtronic
Boston Scientific
JNJ
FDA dents J&J's blockbuster hopes for Rybrevant
Pharmaphorum
Tue, 12/17/24 - 11:53 am
JNJ
Rybrevant
FDA
ICER calls out Gilead, J&J, Novartis and more in latest report on 'unsupported' price increases
Fierce Pharma
Thu, 12/12/24 - 11:44 pm
ICER
drug pricing
Gilead Sciences
JNJ
Novartis
Gilead/Arcellx’s anito-cel’s differentiated safety profile challenges J&J/Legend’s Carvykti
BioSpace
Tue, 12/10/24 - 11:41 am
Gilead Sciences
Arcellx
anito-cel
JNJ
Carvykti
Multiple Myeloma
ASH: With survival win against J&J's Darzalex, GSK bolsters case for return of myeloma ADC Blenrep
Fierce Pharma
Mon, 12/9/24 - 09:10 pm
ASH 2024
GSK
Blenrep
JNJ
Darzalex
Multiple Myeloma

Pages